Electronic cigarette use among adolescents in 17 European study sites: findings from the Global Youth Tobacco Survey.


Journal

European journal of public health
ISSN: 1464-360X
Titre abrégé: Eur J Public Health
Pays: England
ID NLM: 9204966

Informations de publication

Date de publication:
01 02 2022
Historique:
pubmed: 26 10 2021
medline: 5 4 2022
entrez: 25 10 2021
Statut: ppublish

Résumé

As new findings on public health implications of electronic cigarette (e-cigarette) use emerge, its surveillance remains of utmost importance. This study examined the latest state of e-cigarette use in youth in 17 European study sites (i.e. 16 countries and the Federation of Bosnia and Herzegovina) using the Global Youth Tobacco Survey (GYTS). This was an observational study. Cross-sectional data on students aged 11-17 years from the latest available GYTS round completed in 17 study sites were used to estimate crude and adjusted prevalence of e-cigarette use by sex and pocket money. Panel GYTS data from five countries were used for the trend analyses. All analyses were weighted to account for the survey design and non-response. Compared to 2014, the age-adjusted prevalence of e-cigarette use more than doubled in Georgia and Italy, and nearly doubled in Latvia. Significantly more male than female students aged 11-17 years reported use of e-cigarettes, with little to no confounding by age, grade and pocket money across countries. Youth with medium or higher amount of pocket money was 20-200% more likely to use e-cigarettes than those with fewer to no pocket money in 14 study sites. As e-cigarette use is becoming widespread throughout the world, there is variation in use among and between countries. Expanded and consistent surveillance of e-cigarette use by all World Health Organization member states is essential to generate data on the extent and correlates of youth e-cigarette use for evidence-based planning and evaluation of the electronic nicotine delivery systems and electronic non-nicotine delivery systems national and global control programmes.

Sections du résumé

BACKGROUND
As new findings on public health implications of electronic cigarette (e-cigarette) use emerge, its surveillance remains of utmost importance. This study examined the latest state of e-cigarette use in youth in 17 European study sites (i.e. 16 countries and the Federation of Bosnia and Herzegovina) using the Global Youth Tobacco Survey (GYTS).
METHODS
This was an observational study. Cross-sectional data on students aged 11-17 years from the latest available GYTS round completed in 17 study sites were used to estimate crude and adjusted prevalence of e-cigarette use by sex and pocket money. Panel GYTS data from five countries were used for the trend analyses. All analyses were weighted to account for the survey design and non-response.
RESULTS
Compared to 2014, the age-adjusted prevalence of e-cigarette use more than doubled in Georgia and Italy, and nearly doubled in Latvia. Significantly more male than female students aged 11-17 years reported use of e-cigarettes, with little to no confounding by age, grade and pocket money across countries. Youth with medium or higher amount of pocket money was 20-200% more likely to use e-cigarettes than those with fewer to no pocket money in 14 study sites.
DISCUSSION
As e-cigarette use is becoming widespread throughout the world, there is variation in use among and between countries. Expanded and consistent surveillance of e-cigarette use by all World Health Organization member states is essential to generate data on the extent and correlates of youth e-cigarette use for evidence-based planning and evaluation of the electronic nicotine delivery systems and electronic non-nicotine delivery systems national and global control programmes.

Identifiants

pubmed: 34694383
pii: 6409897
doi: 10.1093/eurpub/ckab180
pmc: PMC8807119
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

126-132

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Public Health Association.

Références

J Psychiatr Res. 2014 Jul;54:43-54
pubmed: 24680203
Can J Public Health. 2019 Feb;110(1):93-102
pubmed: 30168041
Tob Control. 2007 Oct;16(5):329-35
pubmed: 17897992
Int J Environ Res Public Health. 2021 Jan 05;18(1):
pubmed: 33466304
Prev Med. 2020 Feb 3;133:106009
pubmed: 32027913
BMC Public Health. 2021 Jun 3;21(1):954
pubmed: 34078351
Subst Use Misuse. 2017 Feb 23;52(3):332-339
pubmed: 27767370
Health Educ Res. 1997 Sep;12(3):385-97
pubmed: 10174221
Int J Environ Res Public Health. 2018 Apr 08;15(4):
pubmed: 29642480
JAMA Pediatr. 2018 Feb 1;172(2):181-187
pubmed: 29297010
Drug Alcohol Depend. 2015 Aug 1;153:140-4
pubmed: 26077606
Int J Environ Res Public Health. 2019 Dec 27;17(1):
pubmed: 31892159
PLoS One. 2015 May 27;10(5):e0126419
pubmed: 26018542
Curr Addict Rep. 2017 Dec;4(4):422-430
pubmed: 29545987
Am J Public Health. 2020 Feb;110(2):163-165
pubmed: 31855480
Nicotine Tob Res. 2014 Jan;16 Suppl 1:S16-23
pubmed: 23709614
Prev Med. 2020 Feb;131:105903
pubmed: 31812559
J Adolesc Health. 2011 Nov;49(5):542-6
pubmed: 22018571
Drug Alcohol Depend. 2019 Oct 1;203:1-7
pubmed: 31386973
N Z Med J. 2002 Jul 26;115(1158):U108
pubmed: 12362183
Pediatrics. 2015 Jan;135(1):e43-51
pubmed: 25511118
BMJ Open. 2020 Feb 28;10(2):e034760
pubmed: 32114476
Tob Control. 2020 May 15;:
pubmed: 32414867
Aust N Z J Public Health. 2018 Jun;42(3):303-308
pubmed: 29528527

Auteurs

Yelena Tarasenko (Y)

Department of Biostatistics, Epidemiology and Environmental Health Sciences, Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, GA, USA.
Division of Country Health Programmes, Regional Office for Europe, World Health Organization, WHO European Office for the Prevention and Control of NCDs, Moscow, Russian Federation.

Angela Ciobanu (A)

Division of Country Health Programmes, Regional Office for Europe, World Health Organization, WHO European Office for the Prevention and Control of NCDs, Moscow, Russian Federation.

Ranti Fayokun (R)

No Tobacco Unit, Healthier Populations Division, Health Promotion Department, World Health Organisation, Geneva, Switzerland.

Elizaveta Lebedeva (E)

Division of Country Health Programmes, Regional Office for Europe, World Health Organization, WHO European Office for the Prevention and Control of NCDs, Moscow, Russian Federation.

Alison Commar (A)

No Tobacco Unit, Healthier Populations Division, Health Promotion Department, World Health Organisation, Geneva, Switzerland.

Kristina Mauer-Stender (K)

Division of Country Support and Emergencies, Regional Office for Europe, World Health Organization, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH